ADNI | |||||
CN Ab-/Tau- (n=199) | CN Ab+ (n=119) | MCI Ab+ (n=97) | AD dementia (n=59) | p-value | |
Age, years | 70.88 (6.40)†,‡,§ | 74.64 (7.39)* | 74.77 (7.40)* | 76.20 (9.33)* | <0.001 |
Sex, M/F | 72 / 127 | 44 / 75 | 51 / 46 | 31 / 28 | 0.011 |
Education, years | 16.78 (2.28)§ | 16.68 (2.38)§ | 16.11 (2.46) | 15.44 (2.41)*,† | <0.001 |
MMSE | 29.19 (1.07)‡,§ | 28.91 (1.36)‡,§ | 27.49 (2.19)*,†,§ | 22.19 (3.96)*,†,‡ | <0.001 |
APOE e4 carriers -/+a | 136- / 51+†,‡,§ | 54- / 60+* | 29- / 53+* | 18- / 32+* | <0.001 |
Mean tau-PET follow-up, yearsb | 1.72 (0.53) | 1.64 (0.57) | 1.45 (0.71) | 1.37 (0.49) | 0.299 |
BioFINDER-1 | |||||
CN Ab-/Tau- (n=36) | CN Ab+ (n=30) | MCI Ab+ (n=26) | AD dementia (n=46) | p-value | |
Age, years | 73.86 (7.27) | 73.80 (7.44) | 71.73 (9.72) | 71.43 (7.34) | 0.274 |
Sex, M/F | 19 / 17 | 12 / 18 | 18 / 8 | 25 / 21 | 0.187 |
Education, years | 12.42 (3.80) | 11.93 (3.72) | 12.21 (3.93) | 12.22 (3.75) | 0.928 |
MMSE | 28.86 (1.10)‡,§ | 28.83 (1.15)‡,§ | 25.58 (3.06)*,†,§ | 20.96 (4.87)*,†,‡ | < 0.001 |
APOE e4 carriers -/+ | 29- / 7+†,‡,§ | 8- / 22+* | 6- / 20+* | 19- / 27+* | < 0.001 |
Mean tau-PET follow-up, yearsc | 2.03 (0.47) | 1.94 (0.32) | 1.82 (0.12) | 1.87 (0.34) | 0.470 |